NDC properties for "Amjevita 40 MG per 0.4 ML Auto-Injector" (RxCUI 2663910)
About this data
The tables show NDC propoerties for Amjevita 40 MG per 0.4 ML Auto-Injector with the RxCUI 2663910
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Amjevita 40 MG per 0.4 ML Auto-Injector (RxCUI 2663910)
| BLA | BLA761024 |
|---|---|
| MMSL_CODE | BD39992 |
| RxCUI | 2663910 |
| SPL_SET_ID | 9c44bd5b-4464-40a4-8933-8680950f00f2 |
| SPL_SET_ID | b7178e36-6787-45ab-8fee-be59bc6a4aa4 |
| SPL_SET_ID | d7862491-2634-4402-b001-dcc1abf8dd58 |
| Prescribable Synonym | AMJEVITA 40 MG in 0.4 ML Auto-Injector |
| RXNAV_STR | Amjevita 40 MG per 0.4 ML Auto-Injector |
| RxNorm Name | 0.4 ML adalimumab-atto 100 MG/ML Auto-Injector [Amjevita] |
| RxNorm Synonym | Amjevita 40 MG per 0.4 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2663910) |
NDC Properties
NDC Item 55513048201
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-01 |
| NDC Item | 55513048201 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 55513048202
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-02 |
| NDC Item | 55513048202 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 72511048201
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-01 |
| NDC Item | 72511048201 |
| Packaging | 1 SYRINGE in 1 CARTON (72511-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 72511048202
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-02 |
| NDC Item | 72511048202 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 84612048201
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-01 |
| NDC Item | 84612048201 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |
NDC Item 84612048202
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-02 |
| NDC Item | 84612048202 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |
NDC Item 55513048201
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-01 |
| NDC Item | 55513048201 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 55513048202
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-02 |
| NDC Item | 55513048202 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 72511048201
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-01 |
| NDC Item | 72511048201 |
| Packaging | 1 SYRINGE in 1 CARTON (72511-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 72511048202
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-02 |
| NDC Item | 72511048202 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 84612048201
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-01 |
| NDC Item | 84612048201 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |
NDC Item 84612048202
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-02 |
| NDC Item | 84612048202 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |
NDC Item 55513048201
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-01 |
| NDC Item | 55513048201 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 55513048202
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-02 |
| NDC Item | 55513048202 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 72511048201
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-01 |
| NDC Item | 72511048201 |
| Packaging | 1 SYRINGE in 1 CARTON (72511-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 72511048202
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-02 |
| NDC Item | 72511048202 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 84612048201
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-01 |
| NDC Item | 84612048201 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |
NDC Item 84612048202
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-02 |
| NDC Item | 84612048202 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |
NDC Item 55513048201
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-01 |
| NDC Item | 55513048201 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 55513048202
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-02 |
| NDC Item | 55513048202 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 72511048201
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-01 |
| NDC Item | 72511048201 |
| Packaging | 1 SYRINGE in 1 CARTON (72511-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 72511048202
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-02 |
| NDC Item | 72511048202 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 84612048201
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-01 |
| NDC Item | 84612048201 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |
NDC Item 84612048202
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-02 |
| NDC Item | 84612048202 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |
NDC Item 55513048201
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-01 |
| NDC Item | 55513048201 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 55513048202
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-02 |
| NDC Item | 55513048202 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 72511048201
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-01 |
| NDC Item | 72511048201 |
| Packaging | 1 SYRINGE in 1 CARTON (72511-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 72511048202
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-02 |
| NDC Item | 72511048202 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 84612048201
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-01 |
| NDC Item | 84612048201 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |
NDC Item 84612048202
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-02 |
| NDC Item | 84612048202 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |
NDC Item 55513048201
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-01 |
| NDC Item | 55513048201 |
| Packaging | 1 SYRINGE in 1 CARTON (55513-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 55513048202
| NDC 9 | 55513-482 |
|---|---|
| NDC 10 | 55513-482-02 |
| NDC Item | 55513048202 |
| Packaging | 2 SYRINGE in 1 CARTON (55513-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 55513-482 |
NDC Item 72511048201
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-01 |
| NDC Item | 72511048201 |
| Packaging | 1 SYRINGE in 1 CARTON (72511-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 72511048202
| NDC 9 | 72511-482 |
|---|---|
| NDC 10 | 72511-482-02 |
| NDC Item | 72511048202 |
| Packaging | 2 SYRINGE in 1 CARTON (72511-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72511-482 |
NDC Item 84612048201
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-01 |
| NDC Item | 84612048201 |
| Packaging | 1 SYRINGE in 1 CARTON (84612-482-01) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |
NDC Item 84612048202
| NDC 9 | 84612-482 |
|---|---|
| NDC 10 | 84612-482-02 |
| NDC Item | 84612048202 |
| Packaging | 2 SYRINGE in 1 CARTON (84612-482-02) / .4 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 858781 |
| Labeler | Optum Health Solutions (Ireland) Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-01-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 84612-482 |